Rontalizumab
Rontalizumab is a humanized IgG1 monoclonal antibody targets IFN-α. Rontalizumab can be used for the research of systemic lupus erythematosus[1].
Read more
€0.00
(tax incl.)
Reference:
HY-P99267
Brand: